Apellis Pharmaceuticals Inc. (APLS)
Apellis Pharmaceuticals, Inc. (APLS) expects data readouts from its two phase 3 studies (DERBY and OAKS) by September 2021. If positive, then patients with geographic atrophy could have a long awaited treatment options. Further, the results of these trials will have a large impact on the company’s valuation. In this blog post I share my thoughts of intravitreal pegcetacoplan phase 1b and phase 2 clinical trial data. Additionally, I share my expectations on the likelihood of seeing positive data readouts in the phase 3 DERBY and OAKS clinical trials of intravitreal pegcetacoplan in geographic atrophy (GA).
Small Company Spotlight: Xenon Pharmaceuticals (XENE)
A company focused on addressing neurological disorders. I take a look at this company and their prospects prior to their upcoming proof of concept readout by the September-October 2021 timeframe.
Ascendis Pharma A/S (ASND)
Ascendis Pharma A/S (ASND) has a number of key company updates up until the first quarter of 2022. There are regulatory decisions expected from the FDA and EMA before the end of this year. However, I would like to focus on upcoming TrasCon PTH (palopegteriparatide) phase 3 data readout in adults with hypoparathyroidism expected by the first quarter of 2022.
Small Company Spotlight: Theravance Biopharma (TBPH)
Theravance Biopharma (TBPH) has two data readouts in Q3 2021, but the izencitinib phase 2b data readout from the phase 2b/3 study of izencitnib in Ulcerative Colitis is likely the most interesting to investors. I share my thoughts on TBPH prior to their izencitinib phase 2b data readout this quarter.
Regulatory Affairs Q&A (Part 2)
What careers and job opportunities are available in regulatory affairs (and government affairs)? In this post, I discuss some of the job options available to those working in regulatory and government affairs.
The Pros and Cons of the Public Service Loan Forgiveness (PSLF) Program
What is the PSLF (Public Service Loan Forgiveness) program? Why should I consider the PSLF program? Why should I care about the PSLF program? Do I qualify for PSLF? What are the risks that come with the PSLF program? In this post, I highlight the PSLF program and why student Pharmacists and Pharmacists should consider if the PSLF aligns with their goals.
Singular Genomics Systems, Inc. (OMIC)
In this requested blog post, I share my initial thoughts of a recent initial public offering (IPO) for Singular Genomics, Inc. (OMIC).
Regulatory Affairs Q&A (Part 1)
What is it like working in Regulatory Affairs? In this post, I answer some questions I commonly get about working in regulatory affairs.
Six Strategies to Sack Student Loans
How do you pay off student loans? In this post, I share six examples of strategies you can consider to help pay down student loan debt.
Curious Curis (CRIS) Pull-Back
I try to figure out why Curis, Inc. (CRIS) had its stock price punished by almost 37% in a single day on the tails of what initially appeared as a positive announcement for the company and its CA-4948 asset.